Related Experiment Video
Updated: Dec 28, 2025
12:59
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
13.0K
Myasthenia Gravis with Elderly Onset at Advanced Age
Otto Jesus Hernandez Fustes1, Carlos Arteaga Rodriguez2, Olga Judith Hernandez Fustes3
1Neurology, Complexo Hospital de Clínicas - Universidade Federal do Paraná (CHC- UFPR), Curitiba, BRA.
Cureus
|February 11, 2020
Summary
Myasthenia gravis in older adults is understudied but increasingly prevalent. Early diagnosis and treatment are crucial for better outcomes in geriatric patients.
Area of Science:
- Neurology
- Geriatrics
Background:
- Myasthenia gravis (MG) in older adults requires more research.
- Epidemiological studies suggest a higher prevalence in the elderly.
- Diagnosis can be challenging in patients over 70 due to confounding conditions.
Observation:
- An 85-year-old female presented with speech and swallowing difficulties.
- Neurological examination revealed palpebral ptosis, dysphonia, strabismus, and progressive limb weakness.
- Electroneuromyography and acetylcholine receptor antibody tests were performed.
Findings:
- The patient was diagnosed with Myasthenia Gravis.
- The case highlights diagnostic challenges in geriatric populations.
- Prompt, specific treatment is vital for improving prognosis in elderly MG patients.
Implications:
- Emphasizes the importance of considering Myasthenia Gravis in geriatric patients.
- Highlights the need for increased awareness and research into late-onset MG.
- Suggests that timely diagnosis and intervention can significantly improve outcomes and reduce mortality in older adults with MG.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
2.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.6K
01:15Myasthenia Gravis: Diagnostic Tests
1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
01:28Disorders of the Skeletal Muscle
1.6K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
01:15Drug Dosing: Geriatric Patients
174
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
174
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
147
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
147
01:26Chemical Synapses
11.0K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
11.0K